Editors note: Ortho-McNeil Neurologics, Inc., announced on April 11, 2007, that their form name Reminyl (galantamine hydrobromide) would be changed to Razadyne in solvent to FDA reports of prescribing and dispensing errors due to cognitive province of the names Reminyl and the diabetes drug Amaryl (glimepiride), which is marketed by Sanofi-Aventis.
Oct. 26, 2007
This is a part of article Amaryl Substituted for Reminyl Causes Hypoglycemia, Death Taken from "Glimepiride Amaryl Tablets" Information Blog
Saturday, January 26, 2008
Amaryl Substituted for Reminyl Causes Hypoglycemia, Death
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment